Berber Zweedijk

Endovascular Treatment With or Without Prior Intravenous Alteplase for Acute Ischemic Stroke

Hester F. Lingsma, Ivo G. H. Jansen, L. Beenen, 2019, Journal of the American Heart Association.

Path From Clinical Research to Implementation

Ivo G. H. Jansen, P. M. Janssen, L. Beenen, 2020, Stroke.

Workflow Intervals of Endovascular Acute Stroke Therapy During On- Versus Off-Hours: The MR CLEAN Registry.

Hester F. Lingsma, Ivo G. H. Jansen, L. Beenen, 2019, Stroke.

Interhospital transfer vs. direct presentation of patients with a large vessel occlusion not eligible for IV thrombolysis

Hester F. Lingsma, Ivo G. H. Jansen, L. Beenen, 2020, Journal of Neurology.

Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial

A. Algra, J. Hofmeijer, L. Kappelle, 2021, The Lancet Neurology.

Improving quality of stroke care through benchmarking center performance: why focusing on outcomes is not enough

Hester F. Lingsma, Ivo G. H. Jansen, Adrien E. D. Groot, 2020, BMC Health Services Research.

Association between thrombus composition and stroke etiology in the MR CLEAN Registry biobank

Hester F. Lingsma, Ivo G. H. Jansen, L. Beenen, 2023, Neuroradiology.

Endovascular Treatment

Hester F. Lingsma, Ivo G. H. Jansen, L. Beenen, 2019, Stroke.

Effect of First‐Pass Reperfusion on Outcome After Endovascular Treatment for Ischemic Stroke

Ivo G. H. Jansen, L. Beenen, E. Venema, 2021, Journal of the American Heart Association.